The Gut Microbiome as a Regulator of the Neuroimmune Landscape

Literature Cited

1. 1. 

   Thion MS, Ginhoux F, Garel S 2018. Microglia and early brain development: an intimate journey. Science 362:185–89
   [Google Scholar]
2. 2. 

   Hickman S, Izzy S, Sen P, Morsett L, El Khoury J. 2018. Microglia in neurodegeneration. Nat. Neurosci. 21:1359–69
   [Google Scholar]
3. 3. 

   Wolf SA, Boddeke HW, Kettenmann H. 2017. Microglia in physiology and disease. Annu. Rev. Physiol. 79:619–43
   [Google Scholar]
4. 4. 

   Erny D, Hrabe de Angelis AL, Jaitin D, Wieghofer P, Staszewski O et al. 2015. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 18:965–77
   [Google Scholar]
5. 5. 

   Matcovitch-Natan O, Winter DR, Giladi A, Vargas Aguilar S, Spinrad A et al. 2016. Microglia development follows a stepwise program to regulate brain homeostasis. Science 353:aad8670
   [Google Scholar]
6. 6. 

   Thion MS, Low D, Silvin A, Chen J, Grisel P et al. 2018. Microbiome influences prenatal and adult microglia in a sex-specific manner. Cell 172:500–16.e16
   [Google Scholar]
7. 7. 

   Castillo-Ruiz A, Mosley M, George AJ, Mussaji LF, Fullerton EF et al. 2018. The microbiota influences cell death and microglial colonization in the perinatal mouse brain. Brain Behav. Immun. 67:218–29
   [Google Scholar]
8. 8. 

   Luck B, Engevik MA, Ganesh BP, Lackey EP, Lin T et al. 2020. Bifidobacteria shape host neural circuits during postnatal development by promoting synapse formation and microglial function. Sci. Rep. 10:7737
   [Google Scholar]
9. 9. 

   Lu J, Lu L, Yu Y, Baranowski J, Claud EC. 2020. Maternal administration of probiotics promotes brain development and protects offspring's brain from postnatal inflammatory insults in C57/BL6J mice. Sci. Rep. 10:8178
   [Google Scholar]
10. 10. 

    Dodiya HB, Kuntz T, Shaik SM, Baufeld C, Leibowitz J et al. 2019. Sex-specific effects of microbiome perturbations on cerebral Aβ amyloidosis and microglia phenotypes. J. Exp. Med. 216:1542–60
    [Google Scholar]
11. 11. 

    Chu C, Murdock MH, Jing D, Won TH, Chung H et al. 2019. The microbiota regulate neuronal function and fear extinction learning. Nature 574:543–48
    [Google Scholar]
12. 12. 

    Diaz Heijtz R, Wang S, Anuar F, Qian Y, Bjorkholm B et al. 2011. Normal gut microbiota modulates brain development and behavior. PNAS 108:3047–52
    [Google Scholar]
13. 13. 

    Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR et al. 2012. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74:691–705
    [Google Scholar]
14. 14. 

    Stephan AH, Barres BA, Stevens B. 2012. The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci. 35:369–89
    [Google Scholar]
15. 15. 

    Fonseca MI, Chu SH, Hernandez MX, Fang MJ, Modarresi L et al. 2017. Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain. J. Neuroinflamm. 14:48
    [Google Scholar]
16. 16. 

    Pronovost GN, Hsiao EY. 2019. Perinatal interactions between the microbiome, immunity, and neurodevelopment. Immunity 50:18–36
    [Google Scholar]
17. 17. 

    Yoshiya K, Lapchak PH, Thai TH, Kannan L, Rani P et al. 2011. Depletion of gut commensal bacteria attenuates intestinal ischemia/reperfusion injury. Am. J. Physiol. Gastrointest. Liver Physiol. 301:G1020–30
    [Google Scholar]
18. 18. 

    Meisel JS, Sfyroera G, Bartow-McKenney C, Gimblet C, Bugayev J et al. 2018. Commensal microbiota modulate gene expression in the skin. Microbiome 6:20
    [Google Scholar]
19. 19. 

    Shi Q, Chowdhury S, Ma R, Le KX, Hong S et al. 2017. Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice. Sci. Transl. Med. 9:eaaf6295
    [Google Scholar]
20. 20. 

    Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S et al. 2016. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352:712–16
    [Google Scholar]
21. 21. 

    Lui H, Zhang J, Makinson SR, Cahill MK, Kelley KW et al. 2016. Progranulin deficiency promotes circuit-specific synaptic pruning by microglia via complement activation. Cell 165:921–35
    [Google Scholar]
22. 22. 

    Veerhuis R, Nielsen HM, Tenner AJ. 2011. Complement in the brain. Mol. Immunol. 48:1592–603
    [Google Scholar]
23. 23. 

    Shi Q, Colodner KJ, Matousek SB, Merry K, Hong S et al. 2015. Complement C3-deficient mice fail to display age-related hippocampal decline. J. Neurosci. 35:13029–42
    [Google Scholar]
24. 24. 

    Maier M, Peng Y, Jiang L, Seabrook TJ, Carroll MC, Lemere CA 2008. Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice. J. Neurosci. 28:6333–41
    [Google Scholar]
25. 25. 

    Zysset-Burri DC, Keller I, Berger LE, Largiader CR, Wittwer M et al. 2020. Associations of the intestinal microbiome with the complement system in neovascular age-related macular degeneration. NPJ Genom. Med. 5:34
    [Google Scholar]
26. 26. 

    Feng W, Ao H, Peng C. 2018. Gut microbiota, short-chain fatty acids, and herbal medicines. Front. Pharmacol. 9:1354
    [Google Scholar]
27. 27. 

    Pasciuto E, Burton OT, Roca CP, Lagou V, Rajan WD et al. 2020. Microglia require CD4 T cells to complete the fetal-to-adult transition. Cell 182:625–40.e24
    [Google Scholar]
28. 28. 

    Sanmarco LM, Wheeler MA, Gutiérrez-Vázquez C, Polonio CM, Linnerbauer M et al. 2021. Gut-licensed IFNγ⁺ NK cells drive LAMP1⁺TRAIL⁺ anti-inflammatory astrocytes. Nature 590:473–79
    [Google Scholar]
29. 29. 

    Fitzpatrick Z, Frazer G, Ferro A, Clare S, Bouladoux N et al. 2020. Gut-educated IgA plasma cells defend the meningeal venous sinuses. Nature 587:472–76
    [Google Scholar]
30. 30. 

    Alves de Lima K, Rustenhoven J, Da Mesquita S, Wall M, Salvador AF et al. 2020. Meningeal γδ T cells regulate anxiety-like behavior via IL-17a signaling in neurons. Nat. Immunol. 21:1421–29
    [Google Scholar]
31. 31. 

    Eltokhi A, Janmaat IE, Genedi M, Haarman BCM, Sommer IEC. 2020. Dysregulation of synaptic pruning as a possible link between intestinal microbiota dysbiosis and neuropsychiatric disorders. J. Neurosci. Res. 98:1335–69
    [Google Scholar]
32. 32. 

    Wenzel TJ, Gates EJ, Ranger AL, Klegeris A. 2020. Short-chain fatty acids (SCFAs) alone or in combination regulate select immune functions of microglia-like cells. Mol. Cell Neurosci. 105:103493
    [Google Scholar]
33. 33. 

    Shukla S, Tekwani BL. 2020. Histone deacetylases inhibitors in neurodegenerative diseases, neuroprotection and neuronal differentiation. Front. Pharmacol. 11:537
    [Google Scholar]
34. 34. 

    Schulthess J, Pandey S, Capitani M, Rue-Albrecht KC, Arnold I et al. 2019. The short chain fatty acid butyrate imprints an antimicrobial program in macrophages. Immunity 50:432–45.e7
    [Google Scholar]
35. 35. 

    Wang P, Zhang Y, Gong Y, Yang R, Chen Z et al. 2018. Sodium butyrate triggers a functional elongation of microglial process via Akt-small RhoGTPase activation and HDACs inhibition. Neurobiol. Dis. 111:12–25
    [Google Scholar]
36. 36. 

    Dalile B, Van Oudenhove L, Vervliet B, Verbeke K 2019. The role of short-chain fatty acids in microbiota-gut-brain communication. Nat. Rev. Gastroenterol. Hepatol. 16:461–78
    [Google Scholar]
37. 37. 

    Soliman ML, Rosenberger TA. 2011. Acetate supplementation increases brain histone acetylation and inhibits histone deacetylase activity and expression. Mol. Cell Biochem. 352:173–80
    [Google Scholar]
38. 38. 

    Soliman ML, Puig KL, Combs CK, Rosenberger TA. 2012. Acetate reduces microglia inflammatory signaling in vitro. J. Neurochem. 123:555–67
    [Google Scholar]
39. 39. 

    Brissette CA, Houdek HM, Floden AM, Rosenberger TA. 2012. Acetate supplementation reduces microglia activation and brain interleukin-1β levels in a rat model of Lyme neuroborreliosis. J. Neuroinflamm. 9:249
    [Google Scholar]
40. 40. 

    Soliman ML, Smith MD, Houdek HM, Rosenberger TA. 2012. Acetate supplementation modulates brain histone acetylation and decreases interleukin-1β expression in a rat model of neuroinflammation. J. Neuroinflamm. 9:51
    [Google Scholar]
41. 41. 

    Franco R, Fernandez-Suarez D. 2015. Alternatively activated microglia and macrophages in the central nervous system. Prog. Neurobiol. 131:65–86
    [Google Scholar]
42. 42. 

    Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG et al. 2016. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease. Cell 167:1469–80.e12
    [Google Scholar]
43. 43. 

    Sun MF, Zhu YL, Zhou ZL, Jia XB, Xu YD et al. 2018. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: gut microbiota, glial reaction and TLR4/TNF-alpha signaling pathway. Brain Behav. Immun. 70:48–60
    [Google Scholar]
44. 44. 

    Qiao CM, Sun MF, Jia XB, Li Y, Zhang BP et al. 2020. Sodium butyrate exacerbates Parkinson's disease by aggravating neuroinflammation and colonic inflammation in MPTP-induced mice model. Neurochem. Res. 45:2128–42
    [Google Scholar]
45. 45. 

    Unger MM, Spiegel J, Dillmann KU, Grundmann D, Philippeit H et al. 2016. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls. Parkinsonism Relat. Disord. 32:66–72
    [Google Scholar]
46. 46. 

    Sun J, Li H, Jin Y, Yu J, Mao S et al. 2021. Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway. Brain Behav. Immun. 91:703–15
    [Google Scholar]
47. 47. 

    Srivastav S, Neupane S, Bhurtel S, Katila N, Maharjan S et al. 2019. Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity. J. Nutr. Biochem. 69:73–86
    [Google Scholar]
48. 48. 

    Hou YF, Shan C, Zhuang SY, Zhuang QQ, Ghosh A et al. 2021. Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson's disease. Microbiome 9:34
    [Google Scholar]
49. 49. 

    Jiang Y, Li K, Li X, Xu L, Yang Z. 2021. Sodium butyrate ameliorates the impairment of synaptic plasticity by inhibiting the neuroinflammation in 5XFAD mice. Chem. Biol. Interact. 341:109452
    [Google Scholar]
50. 50. 

    Sun J, Xu J, Yang B, Chen K, Kong Y et al. 2020. Effect of Clostridium butyricum against microglia-mediated neuroinflammation in Alzheimer's disease via regulating gut microbiota and metabolites butyrate. Mol. Nutr. Food Res. 64:e1900636
    [Google Scholar]
51. 51. 

    Colombo AV, Sadler RK, Llovera G, Singh V, Roth S et al. 2021. Microbiota-derived short chain fatty acids modulate microglia and promote Aβ plaque deposition. eLife 10:e59826
    [Google Scholar]
52. 52. 

    Hanke ML, Kielian T. 2011. Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin. Sci. 121:367–87
    [Google Scholar]
53. 53. 

    Okun E, Griffioen KJ, Mattson MP. 2011. Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci 34:269–81
    [Google Scholar]
54. 54. 

    Fiebich BL, Batista CRA, Saliba SW, Yousif NM, de Oliveira ACP. 2018. Role of microglia TLRs in neurodegeneration. Front. Cell Neurosci. 12:329
    [Google Scholar]
55. 55. 

    Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783–801
    [Google Scholar]
56. 56. 

    Qiu C, Yuan Z, He Z, Chen H, Liao Y et al. 2021. Lipopolysaccharide preparation derived from Porphyromonas gingivalis induces a weaker immuno-inflammatory response in BV-2 microglial cells than Escherichia coli by differentially activating TLR2/4-mediated NF-κB/STAT3 signaling pathways. Front. Cell Infect. Microbiol. 11:606986
    [Google Scholar]
57. 57. 

    Eder K, Vizler C, Kusz E, Karcagi I, Glavinas H et al. 2009. The role of lipopolysaccharide moieties in macrophage response to Escherichia coli. Biochem. Biophys. Res. Commun. 389:46–51
    [Google Scholar]
58. 58. 

    Lin HY, Huang CC, Chang KF. 2009. Lipopolysaccharide preconditioning reduces neuroinflammation against hypoxic ischemia and provides long-term outcome of neuroprotection in neonatal rat. Pediatr. Res. 66:254–59
    [Google Scholar]
59. 59. 

    Vartanian KB, Stevens SL, Marsh BJ, Williams-Karnesky R, Lessov NS, Stenzel-Poore MP. 2011. LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury. J. Neuroinflamm. 8:140
    [Google Scholar]
60. 60. 

    Garcia-Bonilla L, Brea D, Benakis C, Lane DA, Murphy M et al. 2018. Endogenous protection from ischemic brain injury by preconditioned monocytes. J. Neurosci. 38:6722–36
    [Google Scholar]
61. 61. 

    Chen Z, Jalabi W, Shpargel KB, Farabaugh KT, Dutta R et al. 2012. Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4. J. Neurosci. 32:11706–15
    [Google Scholar]
62. 62. 

    Mizobuchi H, Yamamoto K, Tsutsui S, Yamashita M, Nakata Y et al. 2020. A unique hybrid characteristic having both pro- and anti-inflammatory phenotype transformed by repetitive low-dose lipopolysaccharide in C8-B4 microglia. Sci. Rep. 10:8945
    [Google Scholar]
63. 63. 

    Mizobuchi H, Yamamoto K, Yamashita M, Inagawa H, Kohchi C, Soma GI. 2020. A novel anti-inflammatory phenotype transformed by repetitive low-dose lipopolysaccharide in primary peritoneal tissue-resident macrophages. Anticancer Res 40:4457–64
    [Google Scholar]
64. 64. 

    Halder SK, Matsunaga H, Ishii KJ, Akira S, Miyake K, Ueda H 2013. Retinal cell type-specific prevention of ischemia-induced damages by LPS-TLR4 signaling through microglia. J. Neurochem. 126:243–60
    [Google Scholar]
65. 65. 

    Schaafsma W, Zhang X, van Zomeren KC, Jacobs S, Georgieva PB et al. 2015. Long-lasting pro-inflammatory suppression of microglia by LPS-preconditioning is mediated by RelB-dependent epigenetic silencing. Brain Behav. Immun. 48:205–21
    [Google Scholar]
66. 66. 

    Lagier JC, Million M, Hugon P, Armougom F, Raoult D. 2012. Human gut microbiota: repertoire and variations. Front. Cell Infect. Microbiol. 2:136
    [Google Scholar]
67. 67. 

    Salguero MV, Al-Obaide MAI, Singh R, Siepmann T, Vasylyeva TL. 2019. Dysbiosis of Gram-negative gut microbiota and the associated serum lipopolysaccharide exacerbates inflammation in type 2 diabetic patients with chronic kidney disease. Exp. Ther. Med. 18:3461–69
    [Google Scholar]
68. 68. 

    Jacobson AN, Choudhury BP, Fischbach MA. 2018. The biosynthesis of lipooligosaccharide from Bacteroides thetaiotaomicron. mBio 9:e02289–17
    [Google Scholar]
69. 69. 

    Yoshida N, Yamashita T, Kishino S, Watanabe H, Sasaki K et al. 2020. A possible beneficial effect of Bacteroides on faecal lipopolysaccharide activity and cardiovascular diseases. Sci. Rep. 10:13009
    [Google Scholar]
70. 70. 

    Steimle A, Michaelis L, Di Lorenzo F, Kliem T, Munzner T et al. 2019. Weak agonistic LPS restores intestinal immune homeostasis. Mol. Ther. 27:1974–91
    [Google Scholar]
71. 71. 

    Zhao Y, Lukiw WJ. 2018. Bacteroidetes neurotoxins and inflammatory neurodegeneration. Mol. Neurobiol. 55:9100–7
    [Google Scholar]
72. 72. 

    Fields CT, Chassaing B, Castillo-Ruiz A, Osan R, Gewirtz AT, de Vries GJ. 2018. Effects of gut-derived endotoxin on anxiety-like and repetitive behaviors in male and female mice. Biol. Sex. Differ. 9:7
    [Google Scholar]
73. 73. 

    Pittman DW, Dong G, Brantly AM, He L, Nelson TS et al. 2020. Behavioral and neurophysiological taste responses to sweet and salt are diminished in a model of subclinical intestinal inflammation. Sci. Rep. 10:17611
    [Google Scholar]
74. 74. 

    Kobayashi Y, Inagawa H, Kohchi C, Okazaki K, Zhang R et al. 2017. Lipopolysaccharides derived from Pantoea agglomerans can promote the phagocytic activity of amyloid β in mouse microglial cells. Anticancer Res 37:3917–20
    [Google Scholar]
75. 75. 

    Kobayashi Y, Inagawa H, Kohchi C, Okazaki K, Zhang R, Soma G. 2016. Effect of lipopolysaccharide derived from Pantoea agglomerans on the phagocytic activity of amyloid β by primary murine microglial cells. Anticancer Res 36:3693–98
    [Google Scholar]
76. 76. 

    Brown DG, Soto R, Yandamuri S, Stone C, Dickey L et al. 2019. The microbiota protects from viral-induced neurologic damage through microglia-intrinsic TLR signaling. eLife 8:e47117
    [Google Scholar]
77. 77. 

    Brown GC. 2019. The endotoxin hypothesis of neurodegeneration. J. Neuroinflamm. 16:180
    [Google Scholar]
78. 78. 

    Zhang R, Miller RG, Gascon R, Champion S, Katz J et al. 2009. Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS). J. Neuroimmunol. 206:121–24
    [Google Scholar]
79. 79. 

    Zhao Y, Cong L, Lukiw WJ. 2017. Lipopolysaccharide (LPS) accumulates in neocortical neurons of Alzheimer's disease (AD) brain and impairs transcription in human neuronal-glial primary co-cultures. Front. Aging Neurosci. 9:407
    [Google Scholar]
80. 80. 

    Emanuele E, Orsi P, Boso M, Broglia D, Brondino N et al. 2010. Low-grade endotoxemia in patients with severe autism. Neurosci. Lett. 471:162–65
    [Google Scholar]
81. 81. 

    Fuke N, Nagata N, Suganuma H, Ota T. 2019. Regulation of gut microbiota and metabolic endotoxemia with dietary factors. Nutrients 11:2277
    [Google Scholar]
82. 82. 

    Sandiego CM, Gallezot JD, Pittman B, Nabulsi N, Lim K et al. 2015. Imaging robust microglial activation after lipopolysaccharide administration in humans with PET. PNAS 112:12468–73
    [Google Scholar]
83. 83. 

    Agus A, Planchais J, Sokol H. 2018. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe 23:716–24
    [Google Scholar]
84. 84. 

    Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA et al. 2009. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. PNAS 106:3698–703
    [Google Scholar]
85. 85. 

    Gutierrez-Vazquez C, Quintana FJ. 2018. Regulation of the immune response by the aryl hydrocarbon receptor. Immunity 48:19–33
    [Google Scholar]
86. 86. 

    Rothhammer V, Quintana FJ. 2019. The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease. Nat. Rev. Immunol. 19:184–97
    [Google Scholar]
87. 87. 

    Tanaka M, Fujikawa M, Oguro A, Itoh K, Vogel CFA, Ishihara Y. 2021. Involvement of the microglial aryl hydrocarbon receptor in neuroinflammation and vasogenic edema after ischemic stroke. Cells 10:718
    [Google Scholar]
88. 88. 

    Matsumoto K, Kinoshita K, Yoshimizu A, Kurauchi Y, Hisatsune A et al. 2020. Laquinimod and 3,3′-diindolylemethane alleviate neuropathological events and neurological deficits in a mouse model of intracerebral hemorrhage. J. Neuroimmunol. 342:577195
    [Google Scholar]
89. 89. 

    Lee YH, Lin CH, Hsu PC, Sun YY, Huang YJ et al. 2015. Aryl hydrocarbon receptor mediates both proinflammatory and anti-inflammatory effects in lipopolysaccharide-activated microglia. Glia 63:1138–54
    [Google Scholar]
90. 90. 

    Huang Y, He J, Liang H, Hu K, Jiang S et al. 2018. Aryl hydrocarbon receptor regulates apoptosis and inflammation in a murine model of experimental autoimmune uveitis. Front. Immunol. 9:1713
    [Google Scholar]
91. 91. 

    Kim SY, Yang HJ, Chang YS, Kim JW, Brooks M et al. 2014. Deletion of aryl hydrocarbon receptor AHR in mice leads to subretinal accumulation of microglia and RPE atrophy. Investig. Ophthalmol. Vis. Sci. 55:6031–40
    [Google Scholar]
92. 92. 

    Shen PX, Li X, Deng SY, Zhao L, Zhang YY et al. 2021. Urolithin A ameliorates experimental autoimmune encephalomyelitis by targeting aryl hydrocarbon receptor. EBioMedicine 64:103227
    [Google Scholar]
93. 93. 

    Rothhammer V, Borucki DM, Tjon EC, Takenaka MC, Chao CC et al. 2018. Microglial control of astrocytes in response to microbial metabolites. Nature 557:724–28
    [Google Scholar]
94. 94. 

    Chen WC, Chang LH, Huang SS, Huang YJ, Chih CL et al. 2019. Aryl hydrocarbon receptor modulates stroke-induced astrogliosis and neurogenesis in the adult mouse brain. J. Neuroinflamm. 16:187
    [Google Scholar]
95. 95. 

    Adesso S, Magnus T, Cuzzocrea S, Campolo M, Rissiek B et al. 2017. Indoxyl sulfate affects glial function increasing oxidative stress and neuroinflammation in chronic kidney disease: interaction between astrocytes and microglia. Front. Pharmacol. 8:370
    [Google Scholar]
96. 96. 

    Adesso S, Paterniti I, Cuzzocrea S, Fujioka M, Autore G et al. 2018. AST-120 reduces neuroinflammation induced by indoxyl sulfate in glial cells. J. Clin. Med. 7:365
    [Google Scholar]
97. 97. 

    Rothhammer V, Mascanfroni ID, Bunse L, Takenaka MC, Kenison JE et al. 2016. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat. Med. 22:586–97
    [Google Scholar]
98. 98. 

    Han RT, Kim RD, Molofsky AV, Liddelow SA. 2021. Astrocyte-immune cell interactions in physiology and pathology. Immunity 54:211–24
    [Google Scholar]
99. 99. 

    Vainchtein ID, Chin G, Cho FS, Kelley KW, Miller JG et al. 2018. Astrocyte-derived interleukin-33 promotes microglial synapse engulfment and neural circuit development. Science 359:1269–73
    [Google Scholar]
100. 100. 

     Bialas AR, Stevens B. 2013. TGF-beta signaling regulates neuronal C1q expression and developmental synaptic refinement. Nat. Neurosci. 16:1773–82
     [Google Scholar]
101. 101. 

     Vainchtein ID, Molofsky AV. 2020. Astrocytes and microglia: in sickness and in health. Trends Neurosci 43:144–54
     [Google Scholar]
102. 102. 

     Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ et al. 2017. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541:481–87
     [Google Scholar]
103. 103. 

     Garcez ML, Tan VX, Heng B, Guillemin GJ. 2020. Sodium butyrate and indole-3-propionic acid prevent the increase of cytokines and kynurenine levels in LPS-induced human primary astrocytes. Int. J. Tryptophan Res. 13: https://doi.org/10.1177/1178646920978404
     [Crossref] [Google Scholar]
104. 104. 

     Kaye J, Piryatinsky V, Birnberg T, Hingaly T, Raymond E et al. 2016. Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor. PNAS 113:E6145–52
     [Google Scholar]
105. 105. 

     Rothhammer V, Kenison JE, Li Z, Tjon E, Takenaka MC et al. 2021. Aryl hydrocarbon receptor activation in astrocytes by laquinimod ameliorates autoimmune inflammation in the CNS. Neurol. Neuroimmunol. Neuroinflamm. 8:e946
     [Google Scholar]
106. 106. 

     Sag D, Ayyildiz ZO, Gunalp S, Wingender G 2019. The role of TRAIL/DRs in the modulation of immune cells and responses. Cancers 11:1469
     [Google Scholar]
107. 107. 

     Ding X, Yan Y, Li X, Li K, Ciric B et al. 2015. Silencing IFN-gamma binding/signaling in astrocytes versus microglia leads to opposite effects on central nervous system autoimmunity. J. Immunol. 194:4251–64
     [Google Scholar]
108. 108. 

     Alves de Lima K, Rustenhoven J, Kipnis J 2020. Meningeal immunity and its function in maintenance of the central nervous system in health and disease. Annu. Rev. Immunol. 38:597–620
     [Google Scholar]
109. 109. 

     Van Hove H, Martens L, Scheyltjens I, De Vlaminck K, Pombo Antunes AR et al. 2019. A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment. Nat. Neurosci. 22:1021–35
     [Google Scholar]
110. 110. 

     Rustenhoven J, Drieu A, Mamuladze T, de Lima KA, Dykstra T et al. 2021. Functional characterization of the dural sinuses as a neuroimmune interface. Cell 184:1000–16.e27
     [Google Scholar]
111. 111. 

     Derecki NC, Cardani AN, Yang CH, Quinnies KM, Crihfield A et al. 2010. Regulation of learning and memory by meningeal immunity: a key role for IL-4. J. Exp. Med. 207:1067–80
     [Google Scholar]
112. 112. 

     Benakis C, Brea D, Caballero S, Faraco G, Moore J et al. 2016. Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells. Nat. Med. 22:516–23
     [Google Scholar]
113. 113. 

     Hapfelmeier S, Lawson MA, Slack E, Kirundi JK, Stoel M et al. 2010. Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science 328:1705–9
     [Google Scholar]
114. 114. 

     Rojas OL, Probstel AK, Porfilio EA, Wang AA, Charabati M et al. 2019. Recirculating intestinal IgA-producing cells regulate neuroinflammation via IL-10. Cell 176:610–24.e18
     [Google Scholar]
115. 115. 

     Hawkins BT, Davis TP. 2005. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 57:173–85
     [Google Scholar]
116. 116. 

     Abbott NJ, Ronnback L, Hansson E 2006. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7:41–53
     [Google Scholar]
117. 117. 

     Banjara M, Ghosh C. 2017. Sterile neuroinflammation and strategies for therapeutic intervention. Int. J. Inflamm. 2017:8385961
     [Google Scholar]
118. 118. 

     Hiippala K, Jouhten H, Ronkainen A, Hartikainen A, Kainulainen V et al. 2018. The potential of gut commensals in reinforcing intestinal barrier function and alleviating inflammation. Nutrients 10:988
     [Google Scholar]
119. 119. 

     Kayama H, Okumura R, Takeda K. 2020. Interaction between the microbiota, epithelia, and immune cells in the intestine. Annu. Rev. Immunol. 38:23–48
     [Google Scholar]
120. 120. 

     Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A et al. 2014. The gut microbiota influences blood-brain barrier permeability in mice. Sci. Transl. Med. 6:263ra158
     [Google Scholar]
121. 121. 

     Sun N, Hu H, Wang F, Li L, Zhu W et al. 2021. Antibiotic-induced microbiome depletion in adult mice disrupts blood-brain barrier and facilitates brain infiltration of monocytes after bone-marrow transplantation. Brain Behav. Immun. 92:102–14
     [Google Scholar]
122. 122. 

     Wu Q, Zhang Y, Zhang Y, Xia C, Lai Q et al. 2020. Potential effects of antibiotic-induced gut microbiome alteration on blood-brain barrier permeability compromise in rhesus monkeys. Ann. N. Y. Acad. Sci. 1470:14–24
     [Google Scholar]
123. 123. 

     Leclercq S, Mian FM, Stanisz AM, Bindels LB, Cambier E et al. 2017. Low-dose penicillin in early life induces long-term changes in murine gut microbiota, brain cytokines and behavior. Nat. Commun. 8:15062
     [Google Scholar]
124. 124. 

     Hoyles L, Snelling T, Umlai UK, Nicholson JK, Carding SR et al. 2018. Microbiome-host systems interactions: protective effects of propionate upon the blood-brain barrier. Microbiome 6:55
     [Google Scholar]
125. 125. 

     Li K, Wei S, Hu L, Yin X, Mai Y et al. 2020. Protection of fecal microbiota transplantation in a mouse model of multiple sclerosis. Mediators Inflamm 2020:2058272
     [Google Scholar]
126. 126. 

     Nelson JW, Phillips SC, Ganesh BP, Petrosino JF, Durgan DJ, Bryan RM. 2021. The gut microbiome contributes to blood-brain barrier disruption in spontaneously hypertensive stroke prone rats. FASEB J 35:e21201
     [Google Scholar]
127. 127. 

     Li H, Sun J, Du J, Wang F, Fang R et al. 2018. Clostridium butyricum exerts a neuroprotective effect in a mouse model of traumatic brain injury via the gut-brain axis. Neurogastroenterol. Motil. 30:e13260
     [Google Scholar]
128. 128. 

     Li H, Sun J, Wang F, Ding G, Chen W et al. 2016. Sodium butyrate exerts neuroprotective effects by restoring the blood-brain barrier in traumatic brain injury mice. Brain Res 1642:70–78
     [Google Scholar]
129. 129. 

     Yang X, Yu D, Xue L, Li H, Du J 2020. Probiotics modulate the microbiota-gut-brain axis and improve memory deficits in aged SAMP8 mice. Acta Pharm. Sin. B 10:475–87
     [Google Scholar]
130. 130. 

     Yu W, Gao D, Wang Z, Jin W, Peng X et al. 2019. Probiotics alleviate cognitive dysfunction associated with neuroinflammation in cardiac surgery. Am. J. Transl. Res. 11:7614–26
     [Google Scholar]
131. 131. 

     Korin B, Ben-Shaanan TL, Schiller M, Dubovik T, Azulay-Debby H et al. 2017. High-dimensional, single-cell characterization of the brain's immune compartment. Nat. Neurosci. 20:1300–9
     [Google Scholar]
132. 132. 

     Prinz M, Priller J. 2017. The role of peripheral immune cells in the CNS in steady state and disease. Nat. Neurosci. 20:136–44
     [Google Scholar]
133. 133. 

     Engelhardt B, Vajkoczy P, Weller RO. 2017. The movers and shapers in immune privilege of the CNS. Nat. Immunol. 18:123–31
     [Google Scholar]
134. 134. 

     Golomb SM, Guldner IH, Zhao A, Wang Q, Palakurthi B et al. 2020. Multi-modal single-cell analysis reveals brain immune landscape plasticity during aging and gut microbiota dysbiosis. Cell Rep 33:108438
     [Google Scholar]
135. 135. 

     Erdo F, Denes L, de Lange E. 2017. Age-associated physiological and pathological changes at the blood-brain barrier: a review. J. Cereb. Blood Flow Metab. 37:4–24
     [Google Scholar]
136. 136. 

     Mohle L, Mattei D, Heimesaat MM, Bereswill S, Fischer A et al. 2016. Ly6C^hi monocytes provide a link between antibiotic-induced changes in gut microbiota and adult hippocampal neurogenesis. Cell Rep 15:1945–56
     [Google Scholar]
137. 137. 

     Celorrio M, Abellanas MA, Rhodes J, Goodwin V, Moritz J et al. 2021. Gut microbial dysbiosis after traumatic brain injury modulates the immune response and impairs neurogenesis. Acta Neuropathol. Commun. 9:40
     [Google Scholar]
138. 138. 

     D'Mello C, Ronaghan N, Zaheer R, Dicay M, Le T et al. 2015. Probiotics improve inflammation-associated sickness behavior by altering communication between the peripheral immune system and the brain. J. Neurosci. 35:10821–30
     [Google Scholar]
139. 139. 

     Fox EJ. 2004. Immunopathology of multiple sclerosis. Neurology 63:S3–7
     [Google Scholar]
140. 140. 

     Mirza A, Forbes JD, Zhu F, Bernstein CN, Van Domselaar G et al. 2020. The multiple sclerosis gut microbiota: a systematic review. Mult. Scler. Relat. Disord. 37:101427
     [Google Scholar]
141. 141. 

     Berer K, Gerdes LA, Cekanaviciute E, Jia X, Xiao L et al. 2017. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. PNAS 114:10719–24
     [Google Scholar]
142. 142. 

     Cekanaviciute E, Yoo BB, Runia TF, Debelius JW, Singh S et al. 2017. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. PNAS 114:10713–18
     [Google Scholar]
143. 143. 

     Cosorich I, Dalla-Costa G, Sorini C, Ferrarese R, Messina MJ et al. 2017. High frequency of intestinal T_H17 cells correlates with microbiota alterations and disease activity in multiple sclerosis. Sci. Adv. 3:e1700492
     [Google Scholar]
144. 144. 

     Balasa R, Barcutean L, Balasa A, Motataianu A, Roman-Filip C, Manu D. 2020. The action of TH17 cells on blood brain barrier in multiple sclerosis and experimental autoimmune encephalomyelitis. Hum. Immunol. 81:237–43
     [Google Scholar]
145. 145. 

     Berer K, Mues M, Koutrolos M, Rasbi ZA, Boziki M et al. 2011. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479:538–41
     [Google Scholar]
146. 146. 

     Miyauchi E, Kim SW, Suda W, Kawasumi M, Onawa S et al. 2020. Gut microorganisms act together to exacerbate inflammation in spinal cords. Nature 585:102–6
     [Google Scholar]
147. 147. 

     Ochoa-Reparaz J, Mielcarz DW, Ditrio LE, Burroughs AR, Foureau DM et al. 2009. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J. Immunol. 183:6041–50
     [Google Scholar]
148. 148. 

     Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. 2011. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. PNAS 108:Suppl. 14615–22
     [Google Scholar]
149. 149. 

     Seifert HA, Benedek G, Nguyen H, Gerstner G, Zhang Y et al. 2018. Antibiotics protect against EAE by increasing regulatory and anti-inflammatory cells. Metab. Brain Dis. 33:1599–607
     [Google Scholar]
150. 150. 

     Godel C, Kunkel B, Kashani A, Lassmann H, Arumugam M, Krishnamoorthy G 2020. Perturbation of gut microbiota decreases susceptibility but does not modulate ongoing autoimmune neurological disease. J. Neuroinflamm. 17:79
     [Google Scholar]
151. 151. 

     Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T et al. 2009. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485–98
     [Google Scholar]
152. 152. 

     Ivanov II, de Llanos Frutos R, Manel N, Yoshinaga K, Rifkin DB et al. 2008. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4:337–49
     [Google Scholar]
153. 153. 

     Goto Y, Panea C, Nakato G, Cebula A, Lee C et al. 2014. Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation. Immunity 40:594–607
     [Google Scholar]
154. 154. 

     Ochoa-Reparaz J, Mielcarz DW, Ditrio LE, Burroughs AR, Begum-Haque S et al. 2010. Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. J. Immunol. 185:4101–8
     [Google Scholar]
155. 155. 

     Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. 2005. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122:107–18
     [Google Scholar]
156. 156. 

     Ochoa-Reparaz J, Mielcarz DW, Wang Y, Begum-Haque S, Dasgupta S et al. 2010. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol 3:487–95
     [Google Scholar]
157. 157. 

     Wang Y, Begum-Haque S, Telesford KM, Ochoa-Reparaz J, Christy M et al. 2014. A commensal bacterial product elicits and modulates migratory capacity of CD39⁺ CD4 T regulatory subsets in the suppression of neuroinflammation. Gut Microbes 5:552–61
     [Google Scholar]
158. 158. 

     Wang Y, Telesford KM, Ochoa-Reparaz J, Haque-Begum S, Christy M et al. 2014. An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling. Nat. Commun. 5:4432
     [Google Scholar]
159. 159. 

     Shahi SK, Freedman SN, Murra AC, Zarei K, Sompallae R et al. 2019. Prevotella histicola, a human gut commensal, is as potent as COPAXONE^® in an animal model of multiple sclerosis. Front. Immunol. 10:462
     [Google Scholar]
160. 160. 

     Mangalam A, Shahi SK, Luckey D, Karau M, Marietta E et al. 2017. Human gut-derived commensal bacteria suppress CNS inflammatory and demyelinating disease. Cell Rep 20:1269–77
     [Google Scholar]
161. 161. 

     Liu S, Rezende RM, Moreira TG, Tankou SK, Cox LM et al. 2019. Oral administration of miR-30d from feces of MS patients suppresses MS-like symptoms in mice by expanding Akkermansia muciniphila. Cell Host Microbe 26:779–94.e8
     [Google Scholar]
162. 162. 

     Zhang T, Li Q, Cheng L, Buch H, Zhang F. 2019. Akkermansia muciniphila is a promising probiotic. Microb. Biotechnol. 12:1109–25
     [Google Scholar]
163. 163. 

     Kuczma MP, Szurek EA, Cebula A, Chassaing B, Jung YJ et al. 2020. Commensal epitopes drive differentiation of colonic T_regs. Sci. Adv. 6:eaaz3186
     [Google Scholar]
164. 164. 

     Trend S, Leffler J, Jones AP, Cha L, Gorman S et al. 2021. Associations of serum short-chain fatty acids with circulating immune cells and serum biomarkers in patients with multiple sclerosis. Sci. Rep. 11:5244
     [Google Scholar]
165. 165. 

     Saresella M, Marventano I, Barone M, La Rosa F, Piancone F et al. 2020. Alterations in circulating fatty acid are associated with gut microbiota dysbiosis and inflammation in multiple sclerosis. Front. Immunol. 11:1390
     [Google Scholar]
166. 166. 

     Olsson A, Gustavsen S, Nguyen TD, Nyman M, Langkilde AR et al. 2021. Serum short-chain fatty acids and associations with inflammation in newly diagnosed patients with multiple sclerosis and healthy controls. Front. Immunol. 12:661493
     [Google Scholar]
167. 167. 

     Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T et al. 2011. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331:337–41
     [Google Scholar]
168. 168. 

     Calvo-Barreiro L, Eixarch H, Cornejo T, Costa C, Castillo M et al. 2021. Selected Clostridia strains from the human microbiota and their metabolite, butyrate, improve experimental autoimmune encephalomyelitis. Neurotherapeutics 18:920–37
     [Google Scholar]
169. 169. 

     Chen H, Ma X, Liu Y, Ma L, Chen Z et al. 2019. Gut microbiota interventions with Clostridium butyricum and norfloxacin modulate immune response in experimental autoimmune encephalomyelitis mice. Front. Immunol. 10:1662
     [Google Scholar]
170. 170. 

     Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J et al. 2013. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504:451–55
     [Google Scholar]
171. 171. 

     Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G et al. 2013. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504:446–50
     [Google Scholar]
172. 172. 

     Park J, Kim M, Kang SG, Jannasch AH, Cooper B et al. 2015. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol 8:80–93
     [Google Scholar]
173. 173. 

     Duscha A, Gisevius B, Hirschberg S, Yissachar N, Stangl GI et al. 2020. Propionic acid shapes the multiple sclerosis disease course by an immunomodulatory mechanism. Cell 180:1067–80.e16
     [Google Scholar]